Share this Post!

The FDA, in its commitment to provide stakeholders with streamlined and improved government services, is developing the FDA eServices Portal System – an online platform for FDA marketing authorization applications.

The FDA wishes to invite stakeholders to use the FDA eServices Portal System through for PCPR Conversion applications. The eServices Portal is in its Pilot Implementation; hence, the scope of the application is limited for the time being:


FDA eServices Portal Pilot Implementation for

PCPR Conversion Applications

Transactions PCPR Conversion
Fees to be Paid Based on Current Issuance on Fees and Charges
(DOH Administrative Order No. 50, s. 2001)
Start of Pilot Implementation 26 July 2021
End of Pilot Implementation 26 August 2021

Please follow Annex A of this Advisory for the Guidelines on PCPR Conversion Applications Using eServices Portal System and Annex B for Procedure on the Use of the FDA eServices Portal System for PCPR Conversion Application.

For comments and suggestions on the FDA eServices Portal, please send them to [email protected].